Champions Oncology (CSBR) Enterprise Value (QoQ) (2010 - 2026)
Champions Oncology (CSBR) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 101.83% |
| Jan 31, 2026 | 16.83% |
| Oct 31, 2025 | 17.87% |
| Jul 31, 2025 | -5.21% |
| Apr 30, 2025 | -205.59% |
| Jan 31, 2025 | -16.27% |
| Oct 31, 2024 | 4.77% |
| Jul 31, 2024 | -10.47% |
| Apr 30, 2024 | 41.82% |
| Jan 31, 2024 | 18.37% |
| Oct 31, 2023 | -12.51% |
| Jul 31, 2023 | 51.57% |
| Apr 30, 2023 | 13.11% |
| Jan 31, 2023 | -7.57% |
| Oct 31, 2022 | -33.65% |
| Jul 31, 2022 | 10.07% |
| Apr 30, 2022 | -3.52% |
| Jan 31, 2022 | -81.27% |
| Oct 31, 2021 | -20.00% |
| Jul 31, 2021 | 14.66% |